| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
167 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
853 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
265 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
741 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
864 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5700799 |
Oxazolidinone antimicrobials containing substituted diazine moieties |
Dec. 23, 1997 |
| 5698546 |
Cyclic polyamines |
Dec. 16, 1997 |
| 5696108 |
Protein kinase C inhibitors |
Dec. 9, 1997 |
| 5696129 |
5-HT.sub.4 antagonists |
Dec. 9, 1997 |
| 5693630 |
Phenylethyl and phenylpropylamines |
Dec. 2, 1997 |
| 5693631 |
Potentiation of the microbicide 2-(thiocyanomethylthio) benzothiazole using an N-alkyl heterocyclic compound |
Dec. 2, 1997 |
| 5693649 |
N-substituted azaheterocyclic carboxylic acids and esters thereof |
Dec. 2, 1997 |
| 5691307 |
O.sup.6 -substituted guanine compositions and methods for depleting O.sup.6 |
Nov. 25, 1997 |
| 5691356 |
Disubstituted heterocyclic thrombin inhibitors |
Nov. 25, 1997 |
| 5688777 |
Inhibition of C. difficile infections by indigestible oligosaccharides |
Nov. 18, 1997 |
| 5688783 |
Salinamides |
Nov. 18, 1997 |
| 5688788 |
N-substituted azaheterocyclic carboxylic acids and esters thereof |
Nov. 18, 1997 |
| 5686444 |
Selected soluble esters of hydroxyl-containing indolocarbazoles |
Nov. 11, 1997 |
| 5686446 |
Aminoalkyloximes |
Nov. 11, 1997 |
| 5686447 |
Aminoalkyloximes for treating depression and affective disorders |
Nov. 11, 1997 |
| 5686483 |
Aminoalkyloximes |
Nov. 11, 1997 |
| 5684021 |
Aminoalkyloximes for treating depression and affective disorders |
Nov. 4, 1997 |
| 5681812 |
Methods and compositions for reducing multidrug resistance |
Oct. 28, 1997 |
| 5679673 |
Aralkyl bridged diazabicycloalkane derivatives for CNS disorders |
Oct. 21, 1997 |
| 5677295 |
Rapamycin 42-oximes and hydroxylamines |
Oct. 14, 1997 |
| 5674862 |
Methods of treating diabetic mellitus and its complications |
Oct. 7, 1997 |
| 5672596 |
Benzo-fused lactams promote release of growth hormone |
Sep. 30, 1997 |
| 5670451 |
Compositions and methods for controlling the growth of microbials in aqueous media |
Sep. 23, 1997 |
| 5670496 |
Treatment for toxoplasmosis with a composition comprising a folate antagonist and a spiropiperidyl derivative of rifamycin S |
Sep. 23, 1997 |
| 5670497 |
Cyclic hydrazine compounds |
Sep. 23, 1997 |
| 5668127 |
Nitroimidazole antibacterial compounds and methods of use thereof |
Sep. 16, 1997 |
| 5668128 |
Aziridine derivatives, their production and use |
Sep. 16, 1997 |
| 5668129 |
N-substituted azaheterocyclic carboxylic acids and esters thereof |
Sep. 16, 1997 |
| 5665707 |
Treatment for toxoplasmosis with a composition comprising a lincosamide and a spiropiperidyl derivative of rifamycik S |
Sep. 9, 1997 |
| 5665756 |
Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
Sep. 9, 1997 |
| 5663161 |
Anti-viral triaza compounds |
Sep. 2, 1997 |
| 5661175 |
Hemiasterlin and geodiamolide TA |
Aug. 26, 1997 |
| 5656260 |
Lactone insect lures |
Aug. 12, 1997 |
| 5656632 |
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands |
Aug. 12, 1997 |
| 5652232 |
Benzolactam derivatives |
Jul. 29, 1997 |
| 5650405 |
Treatment for toxoplasmosis with a composition comprising a sulfonamide and a spiropiperidyl derivative of rifamycin S. |
Jul. 22, 1997 |
| 5650406 |
Adamantane derivative, process for producing the same, and use thereof |
Jul. 22, 1997 |
| 5650407 |
Selected soluble esters of hydroxyl-containing indolocarbazoles |
Jul. 22, 1997 |
| 5648345 |
Treatment for toxoplasmosis with a composition comprising a macrolide antibiotic and a spiropiperidyl derivative of rifamycin S |
Jul. 15, 1997 |
| 5648351 |
Use of macrolides for the treatment of cerebral ischemia |
Jul. 15, 1997 |
| 5643897 |
Treatment for insomnia |
Jul. 1, 1997 |
| 5643901 |
Medicament for treating idiopathic thrombocytopenic purpura |
Jul. 1, 1997 |
| 5641769 |
treatment for toxoplasmoisis with a composition containing a hydroxynaphthoquinone and a spiropiperidyl derivative of rifamycin S. |
Jun. 24, 1997 |
| 5641783 |
Substituted amino alcohol compounds |
Jun. 24, 1997 |
| 5639745 |
Fused-bicyclic lactams as interleukin-1.beta. converting enzyme inhibitors |
Jun. 17, 1997 |
| 5637578 |
Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
Jun. 10, 1997 |
| 5637608 |
9-substituted porphycenes |
Jun. 10, 1997 |
| 5637622 |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
Jun. 10, 1997 |
| 5631275 |
Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
May. 20, 1997 |
| 5629304 |
Therapeutic agent for thrombocytopenia and indolocarbazole derivatives |
May. 13, 1997 |
|
|
|
